JRSIS HEALTH CARE CORPORATION Research and Development Expense
JRSIS HEALTH CARE CORPORATION (JRSS) reported Research and Development Expense of $28.84 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-12-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-12-20
- JRSIS HEALTH CARE CORPORATION research and development expense for the quarter ending 2024-09-30 was $28.84K, a 20.34% decline year-over-year.
- JRSIS HEALTH CARE CORPORATION research and development expense for the quarter ending 2024-06-30 was $9.60K, a 74.97% decline year-over-year.
- JRSIS HEALTH CARE CORPORATION research and development expense for the quarter ending 2024-03-31 was $10.25K, a 66.15% decline year-over-year.
- JRSIS HEALTH CARE CORPORATION research and development expense for the quarter ending 2023-12-31 was $84.42K.
- JRSIS HEALTH CARE CORPORATION research and development expense for fiscal 2023 was $189.27K, a 33.13% decline from fiscal 2022.
- JRSIS HEALTH CARE CORPORATION research and development expense for fiscal 2022 was $283.04K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $28.84K 10-Q · filed 2024-12-20 | $38.44K derived: sum of 2 quarters · filed 2024-12-20 | $48.69K 10-Q · filed 2024-12-20 | $133.12K derived: sum of 4 quarters · filed 2024-12-20 |
| 2024-06-30 | $9.60K 10-Q · filed 2024-09-05 | $19.85K 10-Q · filed 2024-09-05 | $104.28K derived: sum of 3 quarters · filed 2024-09-05 | $140.48K derived: sum of 4 quarters · filed 2024-12-20 |
| 2024-03-31 | $10.25K 10-Q · filed 2024-05-29 | $94.68K derived: sum of 2 quarters · filed 2024-05-29 | $130.88K derived: sum of 3 quarters · filed 2024-12-20 | $169.22K derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-12-31 | $84.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-26 | $120.63K derived: sum of 2 quarters · filed 2024-12-20 | $158.97K derived: sum of 3 quarters · filed 2024-12-20 | $189.27K 10-K · filed 2024-04-26 |
| 2023-09-30 | $36.20K 10-Q · filed 2024-12-20 | $74.55K derived: sum of 2 quarters · filed 2024-12-20 | $104.84K 10-Q · filed 2024-12-20 | |
| 2023-06-30 | $38.34K 10-Q · filed 2024-09-05 | $68.64K 10-Q · filed 2024-09-05 | ||
| 2023-03-31 | $30.30K 10-Q · filed 2024-05-29 | |||
| 2022-12-31 | $283.04K 10-K · filed 2024-04-26 |